StemCell Therapy

Yale Rheumatology State of the Art Symposium: Pre-autoimmunity and the Prevention of Rheumatic Diseases

Recent progress in our understanding of the development of autoimmunity suggests the opportunity of intervening in the prodromal phase of rheumatic diseases to prevent the future onset of clinically-apparent disease, such as arthritis or other disease manifestations.

This one-day international symposium will bring thought leaders together to review the conceptual basis and available clinical data for implementing preventive strategies in rheumatoid arthritis, systemic lupus erythematosus, and other autoimmune and rheumatic conditions. Topics will include the definition of at-risk individuals, interventions under study, and prospects for new approaches in basic scientific and clinical investigation, and for the design of therapeutic clinical trials.

Date: Wednesday, May 19, 2021

Time: 8 a.m - 4 p.m.

Live Zoom webinar

Accreditation Statement

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Yale School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Speakers

Richard Bucala, MD, PhD, Waldemar Von Zedtwitz Professor of Medicine (Rheumatology) and Professor of Pathology and of Epidemiology (Microbial Diseases); Chief, Rheumatology, Allergy, & Immunology; Rheumatologist in Chief, Rheumatology

Ned Calonge, MD, President and CEO, the Colorado Trust

Ben Chong, MD, Assistant Instructor, University of Texas Southwestern Medical Center

Andrew Cope, MD, PhD, Professor of Rheumatology, King's College London

Philip De Jager, MD, PhD, Professor of Neurology, CUMC/Neurological Institute of New York

Kevin Deane, MD, PhD, Associate Professor of Medicine, Division of Rheumatology, University of Colorado Hospital, Veterans Affairs Medical Center

Hani El-Gabalawy, MD, FRCPC, Professor of Medicine and Immunology, University of Manitoba Arthritis Center

Peter C. Grayson, MD, MSc, Tenure Track Investigator, NIAMS Vasculitis Translational Research Program, National Institutes of Health

Mark Harrison, PhD, Associate Professor, Faculty of Pharmaceutical Sciences, University of British Columbia

Andrew Heinrich, JD, MPhil, Lecturer, Yale School of Public Health

Kevan Herold, MD, C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)

Judith James, MD, PhD, Vice President of Clinical Affairs, Oklahoma Medical Research Foundation

David Karp, MD, PhD, Professor and Chief, Rheumatic Disease Division, University of Texas Southwestern Medical Center

Nancy Olsen, MD, Department of Rheumatology, Penn State M.S. Hershey Medical Center

Christopher T. Ritchlin, MD, MPH, Professor of Medicine and Chief - Department of Medicine, Allergy/Immunology and Rheumatology (SMD), University of Rochester Medical Center

Event RSVP: Allison Rentfro, PhD

REGISTRATION FEES: Physicians - $50 Nurses/PAs/Allied Health Professionals - $25 Residents/Fellows/Students - Complimentary Exhibits - $1500

Host Organization: Rheumatology, Allergy, & Immunology

The rest is here:
Yale Rheumatology State of the Art Symposium: Pre-autoimmunity and the Prevention of Rheumatic Diseases, on May 19 - Yale School of Medicine

This entry was posted on May 14, 2021 at 1:55 am and is filed under Arthritis. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |